The overall objective of PD-MitoQUANT is to deepen our understanding of mitochondrial dysfunction in Parkinson’s.
PD-MitoQUANT assembles world-leading experts in a wide range of areas such as mitochondrial function, ageing, cellular models of Parkinson’s, advanced imaging, data-driven machine learning, systems modelling, and more.
The team uses innovative computational, cellular and in vivo models to identify the signatures of progressive mitochondrial dysfunction in Parkinson’s. This, in turn, will identify novel targets for new treatments for this condition and other neurodegenerative diseases.
PD-MitoQUANT develops better models for studying Parkinson’s and builds on their existing expertise in cellular and in vivo models by applying cutting edge technologies, such as super-resolution imaging, innovative microfluidics and 3D ‘Organ-on-a-Chip’ (OrganoPlate®). Check out our overview of PD-MitoQUANT here!